资源描述：
《145例糖尿病足创面病原菌特点及药敏分析》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、145例糖尿病足创面病原菌特点及药敏分析1四川省德阳市人民医院内分泌科，2四川省德阳市人民医院感染管理科，3四川省德阳市人民医院药剂科，4四川省德阳市人民医院检验科Analysisofantimicrobialresistanceandcharacteristicsofpathogenicbacteriaisolatedfrom145patientswithdiabeticfootulcerWANGYanl,YINLi2,QIANCan3,RANXing-wu4,CHENYa-wenl,YINHan-linl,FANLian-lian3,JIANGChun-mei5,
2、LUDanl,WEIHongl1.DepartmentofEndocrinology,People’sHospitalofDeyangCity,Deyang,Sichuan618000,China;2.Departmentofinfectionmanagement,People’sHospitalofDeyangCity;3.DepartmentofPharmacy,People’sHospitalofDeyangCity;4.DepartmentofEndocrinologyandMetabolism,WestChinaHospi
3、tal,SichuanUniversity,Chengdu,Sichuan610041,China;5Departmentofclinicallaboratory,People’sHospitalofDeyangCity.【Abstract】Objective:Toinvestigatetheonsetincentives,clinicalcharacteristics,therapeuticefficacyandprognosisofpatientwithdiabeticfoot.Methods:Theclinicaldataof124patientsw
4、ithdiabeticfootfromJanuary2011toFebruary2015wereanalyzedretrospectively.Results:84caseshadclearincentive.107caseshaddiabeticperipheralneuropathy(DPN)by86.3%,86caseshaddiabeticperipheralvasculardisease(PAD)by69.4%,severePADocclusion38.7%,6caseshadCharcotosteoarthropathyby4.8%.59caseswere
5、completelyhealed,42casesturnedbetter,23caseswereinvalid,15casesweredischargedwithoutcure.HigherWagnergradecorrespondwithpoorertherapeuticefficacy.Conclusions:Mostoftheoccurrencesofdiabeticfoothaveincentives.Thepatientshadoneorseveralofdiabeticchroniccomplications.Thetherapeuticefficacya
6、ndprognosisaresignificantlycorrelatedwithWegnerclassification,DPNandPAD.Thetreatmentstrategyshouldbebasedonmedicinetreatment,effectiveanti-infection,nutritingnerveandimprovingcirculation,correctlylocaltreatment,reasonableapplicationofnewtechnology,newdressingandcomprehensivetreatmentbya
7、multidisciplinaryfootcareteam.【Keywords】Diabeticfootulcer；Pathogenicbacteria；Antimicrobialsusceptibilitytest【摘要】0的了解住院糖尿病足溃疡(DiabetesFootUlcer：DFU)患者局部创面病原菌的分布特点及药敏结果分析，为糖尿病足创面评估和合理使用抗生素提供依据和参考。方法对2011年1月至2015年6月在我院我科住院治疗的145例DFU患者临床资料及细菌培养、药敏试验进行回顾性分析。结果G+菌对利奈唑胺、地W卡星、万古霉素、呋喃妥因
